SCHEMBL16357345

SCHEMBL16357345

c1ccc(-n2ccc3c4c5ccccc5n(-c5cccc(-c6ccncc6)n5)c4ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ THRB P10828 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ MKNK1 Q9BUB5 1/20 0.33
▸ MKNK2 Q9HBH9 1/20 0.33
▸ HTR6 P50406 2/20 0.33
▸ MAPK9 P45984 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.32
▸ ATM Q13315 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16357485 0.94 KMT2A (0.36) MAPTPOLBKMT2AHTTNPSR1
SCHEMBL20426196 0.91 KDM4E (0.38) MAPTPOLBKMT2ACYP1A2CYP3A4
SCHEMBL16357383 0.89 MAPT (0.38) MAPTDYRK1APDE10AALDH1A1CYP19A1
SCHEMBL15073668 0.87 KDM4E (0.41) MAPTPOLBKMT2ACYP1A2CYP3A4
SCHEMBL16357390 0.87 MAPT (0.35) MAPTPOLBKMT2ACYP1A2CYP3A4
SCHEMBL15632212 0.87 KDM4E (0.40) POLBHTTKDM4EATML3MBTL1
SCHEMBL20426198 0.85 L3MBTL1 (0.41) MAPTKMT2AHTTKDM4EATM
SCHEMBL16357535 0.82 KDM4C (0.35) MAPTPOLBKMT2ACYP1A2CYP3A4
SCHEMBL15632133 0.81 DYRK1A (0.37) MAPTPOLBKMT2ACYP1A2CYP3A4
SCHEMBL20427062 0.81 MAPT (0.34) MAPTPOLBKMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-20140374724-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU MAPT 459/4885POLB 3363/4885KMT2A 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback